Adnexus Therapeutics Overview
- Founded
-
2002

- Status
-
Acquired/Merged
- Employees
-
58

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$489M
Adnexus Therapeutics General Information
Description
Developer of Adnectins biologics/medicines in the United States. The company's product candidates include Angiocept/CT-322, an anti-angiogenesis agent for treating cancer that blocks the VEGFR-2 pathway; and other Adnectin therapies for the treatment of oncology, immunology, and cardiovascular diseases.
Contact Information
Website
www.adnexustx.com
Formerly Known As
Compound Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Primary Office
- 100 Beaver Street
- Waltham, MA 02453
- United States
+1 (781) 000-0000
Adnexus Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 01-Oct-2007 | $489M | 000.00 | 00000 | Completed | Startup |
6. IPO | 21-Aug-2007 | 000.00 | Cancelled | Clinical Trials - Phase 2 | ||
5. Early Stage VC | 07-Aug-2007 | 000.00 | 000.00 | Completed | Startup | |
4. Early Stage VC (Series B) | 20-Jun-2006 | 0000 | 000.00 | Completed | Startup | |
3. Convertible Debt | 24-May-2006 | 00.00 | 000.00 | Completed | Startup | |
2. Early Stage VC | 28-Dec-2004 | $15.6M | $22.1M | Completed | Startup | |
1. Early Stage VC (Series A) | 03-Apr-2003 | $6.5M | $6.5M | Completed | Startup |
Adnexus Therapeutics Executive Team (8)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Bruce Silver MD | Medical Director |
Adnexus Therapeutics Signals
Adnexus Therapeutics Former Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Applied Genomic Technology Capital Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
Atlas Venture | Venture Capital | Minority | 000 0000 | 000000 0 | |
Flagship Pioneering | Venture Capital | Minority | 000 0000 | 000000 0 | |
HBM Healthcare Investments | Venture Capital | Minority | 000 0000 | 000000 0 | |
HBM Partners | Venture Capital | Minority | 000 0000 | 000000 0 |